Recruiting
Breast Cancer PSMA PET
NCT06586047
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- University of Iowa Healthcare Iowa City, Iowa, United States
Clinical trial condition
Triple Negative Breast Neoplasms
Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.
846 public trials
302 recruiting studies
Triple Negative Breast Neoplasms trial results
NCT06176261
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Diseases, +11 more
- Locations
-
- Miami Baptist Cancer Institute/ Miami, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Duke University Medical Center Durham, North Carolina, United States
Recruiting
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
NCT07749586
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +92 more
- Locations
-
- Clinical Trial Site Huntersville, North Carolina, United States
- Clinical Trial Site San Antonio, Texas, United States
- Clinical Trial Site Fairfax, Virginia, United States
NCT05318469
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
NCT07078604
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07017673
- Conditions
- Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Cedars-Sinai Medical Center Beverly Hills Los Angeles, California, United States
- Huntington Cancer Center, an Affiliate of CS Cancer Pasadena, California, United States
- Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
Recruiting
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
NCT07739485
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
NCT06081244
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Stadtklinik Baden-Baden / Brustzentrum Baden-Baden, Baden-Wurttemberg, Germany
- Kliniken Böblingen Böblingen, Baden-Wurttemberg, Germany
- Praxis für interdisziplinäre Onkologie & Hämatologie Freiburg im Breisgau, Baden-Wurttemberg, Germany
- SLK Kliniken Heilbronn, Frauenklinik Heilbronn, Baden-Wurttemberg, Germany
NCT06270706
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
- NEXT Austin Austin, Texas, United States